Journal of Adolescent Health
Volume 43, Issue 3 , Pages 239-245, September 2008

Uptake of HPV Vaccine: Demographics, Sexual History and Values, Parenting Style, and Vaccine Attitudes

  • Susan L. Rosenthal, Ph.D.

      Affiliations

    • Department of Pediatrics and Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, Texas
    • Corresponding Author InformationAddress correspondence to: Susan L. Rosenthal, Ph.D., Department of Pediatrics, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-0319
  • ,
  • Richard Rupp, M.D.

      Affiliations

    • Department of Pediatrics and Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, Texas
  • ,
  • Gregory D. Zimet, Ph.D.

      Affiliations

    • Department of Pediatrics, Section of Adolescent Medicine, Indiana University School of Medicine, Indianapolis, Indiana
  • ,
  • Heather M. Meza

      Affiliations

    • Department of Pediatrics and Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, Texas
  • ,
  • Melissa L. Loza

      Affiliations

    • Department of Pediatrics and Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, Texas
  • ,
  • Mary B. Short, Ph.D.

      Affiliations

    • Department of Psychology, University of Houston at Clear Lake, Houston, Texas
  • ,
  • Paul A. Succop, Ph.D.

      Affiliations

    • Department of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, Ohio

Received 3 March 2008; accepted 4 June 2008.

Abstract 

Purpose

To examine the relationships of demographics, parenting, and vaccine attitudes with the acceptance of the human papillomavirus (HPV) vaccine or to the intent to vaccinate in the next 12 months.

Methods

Mothers (n = 153) with daughters ages 11 to 17 years were recruited through the pediatric clinic waiting room/announcements to complete a questionnaire.

Results

Eighteen percent of the daughters had not received the vaccine, although it had been offered; 34% had not been offered the vaccine and did not intend to get it in the next 12 months; 22% had not been offered the vaccine but intended to get it in the next 12 months; 26% had started vaccination or completed the series. In a multinomial, multivariable logistic regression model, those mothers who had less than a high school degree, had a history of a sexually tranmitted infection, supervised their daughter more when she was with peers, and whose daughter would not mind three shots were more likely to be favorable about their daughter being vaccinated. The following variables were not related to their attitudes about getting the vaccine: mothers' and daughters' ages, race/ethnicity, mothers' self-reported history of HPV disease and age of sexual initiation, daughters' dating status and anticipated age of sexual initiation, the number of sexual topics discussed and level of comfort, mother's sexual values, and the family environment.

Conclusions

Mothers' decisions about the HPV vaccine were not related to their sexual values or their daughters' sexual behavior, but rather their parenting, sense of vulnerability, and vaccine attitudes. Mothers who were not planning to vaccinate did not appear to not feel an urgency given the newness of the vaccine, and many planned to vaccinate eventually.

Keywords: HPV, Vaccine, Acceptability, Sexuality, Parenting, Sexually transmitted diseases

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was funded by a grant from Merck Vaccine Division and the National Institute of Health (U 19 AI61972).

PII: S1054-139X(08)00264-4

doi:10.1016/j.jadohealth.2008.06.009

Journal of Adolescent Health
Volume 43, Issue 3 , Pages 239-245, September 2008